FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35875711000001103: Durvalumab 120mg/2.4ml solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110905001000001117 Durvalumab 120mg/2.4ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110905101000001116 Durvalumab 120mg/2.4ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Durvalumab 120mg/2.4ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Is a Durvalumab true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Is a Product containing durvalumab false Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has specific active ingredient Durvalumab true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has active ingredient Durvalumab false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) Is a True Durvalumab 120mg/2.4ml solution for infusion vials Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials 1 vial Has VMP True Durvalumab 120mg/2.4ml solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start